PL328804A1 - Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins - Google Patents

Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins

Info

Publication number
PL328804A1
PL328804A1 PL97328804A PL32880497A PL328804A1 PL 328804 A1 PL328804 A1 PL 328804A1 PL 97328804 A PL97328804 A PL 97328804A PL 32880497 A PL32880497 A PL 32880497A PL 328804 A1 PL328804 A1 PL 328804A1
Authority
PL
Poland
Prior art keywords
immunotoxins
target cells
annihilating
sampled
cells
Prior art date
Application number
PL97328804A
Other languages
English (en)
Inventor
Gunnar Kvalheim
Siri Juell
Meng Yu Wang
Olav Engebraten
Oystein Fodstad
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Publication of PL328804A1 publication Critical patent/PL328804A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PL97328804A 1996-03-13 1997-03-12 Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins PL328804A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO961031A NO961031D0 (no) 1996-03-13 1996-03-13 Fremgangsmåte til å drepe uönskede målceller
PCT/NO1997/000074 WO1997033611A1 (en) 1996-03-13 1997-03-12 Method of killing target cells in harvested cell populations with one or more immunotoxins

Publications (1)

Publication Number Publication Date
PL328804A1 true PL328804A1 (en) 1999-02-15

Family

ID=19899150

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328804A PL328804A1 (en) 1996-03-13 1997-03-12 Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins

Country Status (18)

Country Link
US (1) US7198787B2 (ja)
EP (1) EP0954329B1 (ja)
JP (1) JP2000507230A (ja)
CN (1) CN1218411A (ja)
AT (1) ATE222122T1 (ja)
AU (1) AU710184B2 (ja)
BR (1) BR9708049A (ja)
CA (1) CA2248620A1 (ja)
DE (1) DE69714775T2 (ja)
HU (1) HUP9901597A3 (ja)
IL (1) IL126014A0 (ja)
NO (1) NO961031D0 (ja)
NZ (1) NZ331763A (ja)
PL (1) PL328804A1 (ja)
RU (1) RU2182493C2 (ja)
SK (1) SK125798A3 (ja)
TR (1) TR199801795T2 (ja)
WO (1) WO1997033611A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US7496291B2 (en) * 2006-03-21 2009-02-24 Hewlett-Packard Development Company, L.P. Method and apparatus for interleaved image captures
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
CA3069081C (en) 2008-09-20 2023-05-23 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
AU2009305550B2 (en) * 2008-10-17 2014-06-12 Dana-Farber Cancer Institute, Inc. MUC-1 cytoplasmic domain peptides as inhibitors of cancer
CN102665748A (zh) 2009-05-27 2012-09-12 达娜-法勃肿瘤研究所公司 使用muc1拮抗剂抑制炎症
CN102127148B (zh) * 2010-01-14 2013-04-03 中国农业科学院北京畜牧兽医研究所 血管内皮细胞表面决定簇部分多肽及其应用
ES2641877T3 (es) * 2011-05-06 2017-11-14 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Inmunotoxina recombinante dirigida a mesotelina
CN107748256B (zh) * 2017-10-11 2020-04-14 厦门骁科码生物科技有限公司 一种循环肿瘤细胞的液体活检检测方法

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219411A (en) 1978-09-18 1980-08-26 California Institute Of Technology Cell sorting apparatus
US4230685A (en) 1979-02-28 1980-10-28 Northwestern University Method of magnetic separation of cells and the like, and microspheres for use therein
US4510244A (en) 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US4920061A (en) 1984-03-02 1990-04-24 The University Of Texas System Biological magnetic colloids
US4752569A (en) 1984-06-21 1988-06-21 The Regents Of The University Of California Sialylated Lewisx epitope, antibodies and diagnosis
US5019497A (en) 1984-11-09 1991-05-28 Lennart Olsson Human squamous lung carcinoma cell specific antigens and antibodies
US4710472A (en) 1985-09-25 1987-12-01 The United States Of America As Represented By The Secretary Of The Navy Magnetic separation device
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
EP0241042A3 (en) 1986-04-11 1988-05-04 Hitachi, Ltd. A method for cell analysis
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US4857452A (en) 1986-12-04 1989-08-15 E. I. Du Pont De Nemours And Company Assay for carcinoma of breast, colon and ovary
US5194300A (en) 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
US5322678A (en) 1988-02-17 1994-06-21 Neorx Corporation Alteration of pharmacokinetics of proteins by charge modification
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
FR2638848B1 (fr) 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
DE68919715T2 (de) 1988-12-28 1995-04-06 Stefan Miltenyi Verfahren sowie materialien zur hochgraduierten magnetischen abspaltung biologischer materialien.
US5185254A (en) * 1988-12-29 1993-02-09 The Wistar Institute Gene family of tumor-associated antigens
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
WO1990010692A1 (en) 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia
US5081030A (en) 1989-04-25 1992-01-14 The Johns Hopkins University Release of cells from affinity matrices
DE3919923A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
JPH05503632A (ja) * 1989-12-14 1993-06-17 スローン　―　ケターリング・インスティチュート・フォー・キャンサー・リサーチ モノクローナル抗体ｍ１９５の超可変領域の治療的使用およびその構築
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
GB9007966D0 (en) 1990-04-09 1990-06-06 Dynal As Antigen/anti-antigen cleavage
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
JPH05107249A (ja) 1991-02-04 1993-04-27 Toyobo Co Ltd リガンド・レセプター反応の高感度検出法
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
AU2115092A (en) 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
CA2131090A1 (en) 1992-03-20 1993-09-21 Peter Leonard Grant Method and apparatus for the analysis of biological material
US5422277A (en) 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
WO1994002016A1 (en) * 1992-07-28 1994-02-03 Steven Kessler Methods for positive immunoselection of stem cells
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
ES2123063T3 (es) 1992-09-14 1999-01-01 Stanford Res Inst Int Marcadores convertidores al alza para ensayos biologicos y otros mediante tecnicas de excitacion laser.
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
AUPN214095A0 (en) 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
SK125798A3 (en) 1999-05-07
WO1997033611A1 (en) 1997-09-18
NO961031D0 (no) 1996-03-13
AU710184B2 (en) 1999-09-16
US7198787B2 (en) 2007-04-03
BR9708049A (pt) 1999-07-27
CA2248620A1 (en) 1997-09-18
US20020151689A1 (en) 2002-10-17
IL126014A0 (en) 1999-05-09
HUP9901597A3 (en) 2000-06-28
EP0954329A1 (en) 1999-11-10
TR199801795T2 (xx) 1998-12-21
CN1218411A (zh) 1999-06-02
RU2182493C2 (ru) 2002-05-20
DE69714775D1 (de) 2002-09-19
AU2522997A (en) 1997-10-01
ATE222122T1 (de) 2002-08-15
HUP9901597A2 (hu) 1999-08-30
DE69714775T2 (de) 2003-04-24
JP2000507230A (ja) 2000-06-13
NZ331763A (en) 2000-01-28
EP0954329B1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
EP1100870A4 (en) ENHANCING CARDIAC FUNCTIONING BY TRANSPLANTATION OF MESENCHYMAL STEM CELLS
PL328804A1 (en) Method of annihilating target cells in a sampled cellular population using one or more from among of immunotoxins
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
MXPA02006145A (es) Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina.
AU2730497A (en) Cryopreservation and extensive subculturing of human mesenchymal stem cells
DK0953046T3 (da) Human hæmatopoietisk stam- og progenitorcelleantigen og fremgangsmåder til anvendelse af dette
SG147305A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
EP1083828A4 (en) VASCULAR GRAFT PROSTHESES PREPARED USING BIOLOGICAL TECHNIQUES
EP0846949A4 (en) METHOD FOR DETECTING SOLID CANCER CELLS AND HISTOLOGICAL HETEROTYPES AND METHOD FOR TESTING TISSUE FOR BONE MARKET TRANSPLANTATION AND TRANSPLANTATION OF PERIPHERAL BLOOD STEM CELLS
DE69738753D1 (de) AUF TGF-beta 1 ANSPRECHENDE KNOCHENMARKZELLEN
EP1135531A4 (en) METHODS OF INTRODUCING HETEROLOGOUS CELLS IN FISH
WO2001094541A3 (en) Human mesenchymal progenitor cell
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
HK1023599A1 (en) Cells for preventing graft rejection in transplantation and their uses.
MXPA02005069A (es) Agentes de enlace especificos para t3 y metodos para su uso.
WO2003029432A3 (en) Human mesenchymal progenitor cell
NO984175L (no) FremgangsmÕte til Õ drepe mÕlceller i h°stede cellepopulasjoner med en eller flere immunotoksiner
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
WO1997030354A3 (en) Foetal cell analysis
EP1826560A3 (en) Methods for introducing heterologous cells into fish
DK0846949T3 (da) Fremgangsmåde til påvisning af faste cancerceller og histologiske heterotypier samt fremgangsmåde til undersögelse af væv til knoglemarvstransplantation og perifere stamceller fra blod
MX9706725A (es) Mezclas enzimaticas definidas, novedosas para obtener celulas y para tratamientos de heridas.
UA33888A (uk) Спосіб зменшення імунореактивності алогенного кісткового мозку експериментальних тварин
RU98102969A (ru) Способ трансплантации органов и тканей
UA36518A (uk) Спосіб отримання клітин з ембріонів людини